Frida Sandvik Våset has an integrated master’s degree in biotechnology from the Norwegian University of Science and Technology in Trondheim, with specialization in molecular biology. The title of her Master theses was «Biosimilar Mucus as a Model System for Small Intestinal Mucus». Frida has broad experience in working with production and processing of bull semen in SpermVital, Geno and other customers abroad.

Frida Sandvik Våset has an integrated master’s degree in biotechnology from the Norwegian University of Science and Technology in Trondheim, with specialization in molecular biology. The title of her Master theses was «Biosimilar Mucus as a Model System for Small Intestinal Mucus». Frida has broad experience in working with production and processing of bull semen in SpermVital, Geno and other customers abroad.

Frida Sandvik Våset har en integrert mastergrad i bioteknologi fra NTNU i Trondheim med spesialisering innen moleklyærbiologi. Tittelen på masteroppgaven hennes var «Biosimilar Mucus as a Model System for Small Intestinal Mucus». Frida har mye erfaring med produksjon og prosessering av oksesæd gjennom SpermVital, Geno og samarbeid med kunder internasjonalt.

Marja Mikkola is a veterinarian from Helsinki University, Finland. She holds a PhD from the same institution. She has a broad experience on Assisted Reproduction Technologies (ARTs) in cattle, with special emphasis on female fertility and embryo technologies as well as the application of sex-sorted semen. She has been establishing embryo production systems in Finland and Norway. She is responsible for developing the SpermVital technology further into new products and applications.

Camilla Dehli Østerud has a Master Degree in Molecular Biotechnology from the NMBU Univerity in Ås. Østerud has broad laboratory experience from SpermVital, Geno and other customers abroad.

Tor-Arne Sletmoen built up and managed Geno Global AS until 2016. He has for the past 7 years been regional director for Topigs Norsvin International in Asia, the Nordics, the Baltics, Africa and Russia.

Ingrid Vikøren Mo has an integrated master’s degree in biotechnology from the Norwegian University of Science and Technology in Trondheim with specialization in biopolymers and biomaterials, followed by a PhD within the same specialization. During her PhD project, Ingrid worked with developing new block structures composed of polysaccharides from different sources. Ingrid has worked a lot with marine biopolymers and has broad experience with polysaccharide modification and characterization.

Matthias Ehrlich has studied biology with focus on molecular biology and physiology. He got his master’s degree at the University of Potsdam after completing his thesis in the field of plant cell wall biosynthesis at the Max-Planck-Institute of Molecular Plant Physiology. In addition, he got a graduation as a biological technical assistant. Before he came to Norway, he worked as a scientific fellow at the biological department of LMU Munich focused on enzyme activity and redox regulation in fatty acid biosynthesis. Within these years he got to know different molecular biologic and protein biochemical methods. During the last years, Matthias acquired practical skills at Norwegian dairy farms and since 2018 he is working in production at both Geno and SpermVital.

Kjersti Risbakken is an auditor, and has a extensive experience both as an accountant and as an auditor. She has worked with companies from various industries and sectors both nationally and internationally.

Lill Therese holds a Masters’ degree in Applied and Commercial Biotechnology from Hedmark University College, Norway where she specialized in experimental biotechnology. The title of her Master theses was “Fecal flora in newly diagnosed Inflammatory Bowel Diseases patients”. Lill Therese has a broad experience from laboratory work at Geno where she has been working with processing of both regular and SpermVital semen

Godlove holds a Masters’ degree in Applied and Commercial Biotechnology from Hedmark University College, Norway. Before moving to Norway, he had a Bachelors’ degree in Biochemistry with a minor in Medical Laboratory Technology from The University of Buea, Cameroon. During his Masters degree work, Bai focused on Reproduction Biotechnology with special interest in the development of semen assessment assays for the Norwegian Red (NRF). He has broad practical laboratory experience in both cell and molecular techniques.

Heidi C. L. Spång holds a PhD in immunology and a M.Sc. in molecular biology from Institute of clinical medicine at Oslo University Hospital, with specialization in immunology, and a bachelor degree in molecular biology from the University of Oslo. During her PhD and M.Sc. she worked in the field of DNA vaccine development. She has broad experience in molecular biology, immunology and cell biology.

Eline R. Gaustad has an M.Sc in Applied and Commercial Biotechnology from Hedmark University College, with specialization in experimental biotechnology. She also holds a bachelor degree in molecular biology from the University of Oslo. During her M.Sc thesis she studied the regulation of RNA silencing in plants and algae. Gaustad has laboratory experience in molecular techniques and evaluation of semen quality. In addition she has broad experience from working with production and processing of bull semen at Geno and SpermVital.

Anne Hege Alm-Kristiansen holds a Ph.D. in molecular biology from the Department of Molecular Biosciences at the University of Oslo, Norway. During her Ph.D. and M.Sc. she worked in the field of transcription, studying protein-protein interactions, localization and function. She has broad experience in cell biology, immunology and biochemistry.

Elisabeth Kommisrud is a professor in reproduction biology at Hedmark University College. She is a veterinarian from the Norwegian school of veterinary science, and later she has a PhD from the same institution. She has experience from R&D in the fields of reproduction, with emphasis on spermatology and cryopreservation in several species. Kommisrud has run numerous R&D projects including amongst others the projects which are the basis for the SpermVital technology.

Fride Berg Standerholen has a Ph.D in Reproductive Biology and an M.Sc in Applied and Commercial Biotechnology from Hedmark University College, with specialization in experimental biotechnology and a bachelor degree in Biotechnology from the University of Life Sciences at ÅS. The main goal of the PhD thesis was to gain more knowledge of flow cytometric assessment of semen and procedures for sperm quality assessment. Sperm functionality was assessed in relation to bull semen preservation methods and fertility. One of the main findings was that there were differences in selected sperm function parameters between standard Biladyl (B) and immobilized SpermVital (SV) processed semen. Semen quality parameters, such as plasma membrane- and acrosome integrity, considered important for the actual fertilization, were not correlated with fertility data that showed similar fertility levels between B and SV semen.

Henriette Kise has an MBA in Marketing from Auburn University at Montgomery. She has several years of sales and marketing experience from the pharmaceutical industry in the US. Her responsibilities at SpermVital includes sales and marketing activities in addition to being responsible for establishing contracts with AI companies world wide.